Although there is no cure yet, schizophrenia is highly treatable, with early detection and ongoing treatment.

Depression is more than just a fleeting emotion. This illness hampers a person's daily functioning, negatively impacting their physical health. However, in most cases depression is treatable.    

The Bipolar Disorders Program is a superspecialized (third-line) consultation and treatment service for adults aged 18 to 65 who suffer from refractory bipolar disorders.

The Mood, Anxiety and Impulsivity Disorders Program at the Douglas Institute provides care to people aged 18 to 65 years with a mood disorder such as Bipolar disorders or Depressive and suicide disorders.

Fellowships provide support for senior residents who wish to add to their experience by engaging in mental health research and related activities in the Institute. Candidacy must be approved by the Chair of Psychiatry.

Her current research interests lie in the areas of molecular genetic and personality factors that influence eating disorder symptoms and treatment outcomes.

Ng Ying Kin uses neurochemical analyses to identify peripheral biological markers for various psychiatric disorders.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Howard Steiger contributed to the advancement of knowledge regarding causal mechanisms and clinical management of eating disorders.

Philippe Lageix is Medical Chief, Youth at Risk for Personality Disorders, Douglas Institute